NM_031816.1) was synthesized by using a DIG-labeling kit (Roche Diagnostics, Rotkreuz, Switzerland). The hypothalamic sections were hybridized overnight at 60°C with 1 μg/ml
Rbbp7-specific DIG-labeled anti-sense cRNA probes. The specificity of the cRNA probe was confirmed by performing ISH by using anti-sense and sense probes. No signal was
detected in the brain sections treated with a sense probe. After hybridization, the DIG-labeled probe was detected with alkaline phosphatase-conjugated anti-DIG antibody (1:500; Roche
Diagnostics), and a chromogen solution (0.338 mg/ml 4-nitroblue tetrazolium chloride (NBT; Roche Diagnostics) and 0.175 mg/ml 5-bromo-4-chloro-3-indolyl-phosphate, 4-toluidine salt (BCIP;
Roche Diagnostics). The sections were mounted on gelatin-coated slides and examined under a light microscope (BX53; Olympus, Tokyo, Japan).